Medical Cannabis for Diabetic Polyneuropathy — Switzerland 2026
Vaporised THC reduced diabetic neuropathic pain by up to 30 % in RCTs. Much cheaper prescription for members.
Diabetic polyneuropathy affects 30–50 % of all diabetics. Gabapentin and duloxetine have limited efficacy and heavy side effects. Wallace 2015 (RCT) and Selvarajah 2010: cannabinoids significantly reduce neuropathic pain. CBD-rich preparations and THC micro-doses are standard recommendation. CannabisClub members: 50 CHF flat instead of 190.
What the studies show
Wallace 2015 (RCT, n=16): vaporised THC (1 %, 4 %, 7 %) dose-dependent pain reduction, 7 % dose -30 %.
Selvarajah 2010 (RCT, n=30): nabiximols (Sativex) reduced diabetic nerve pain vs placebo.
Preparations & dosing
CBD oil 50–100 mg twice daily as base — anti-inflammatory, no major interaction with metformin/insulin at usual doses.
THC 2.5–5 mg evenings for sleep disturbance from burning pain.
Important in diabetes
Intensify glucose monitoring — THC may alter insulin sensitivity short-term.
Regular HbA1c checks every 3 months recommended.
Save as a CannabisClub member
Diabetology cannabis consultations cost 190–250 CHF. Members: 50 CHF flat, titration plan included. Registration free.
FAQ
Does cannabis replace my gabapentin?
Can complement/replace in insufficient efficacy or heavy side effects. Switch only with physician.
What does membership save?
50 CHF instead of 190 CHF per consultation. Registration free.
Does insurance cover it?
Neuropathic pain is increasingly covered via art. 71a — we check at the first consultation.
Cannabis for Diabetic Neuropathy — Prescription Switzerland 2026 (Members 50 CHF)